z-logo
open-access-imgOpen Access
In Vivo Generation of Post-infarct Human Cardiac Muscle by Laminin-Promoted Cardiovascular Progenitors
Author(s) -
Lynn Yap,
JiongWei Wang,
Aida MorenoMoral,
Li Yen Chong,
Yi Sun,
Nathan Harmston,
Xiaoyuan Wang,
Suet Yen Chong,
Konstantinos Vanezis,
Miina K. Öhman,
Heming Wei,
Ralph M. Bunte,
Sujoy Gosh,
Stuart A. Cook,
Outi Hovatta,
Dominique P.V. de Kleijn,
Enrico Petretto,
Karl Tryggvason
Publication year - 2019
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2019.02.083
Subject(s) - embryonic stem cell , progenitor cell , biology , laminin , microbiology and biotechnology , induced pluripotent stem cell , in vivo , cellular differentiation , p19 cell , regeneration (biology) , myocyte , stem cell , gene , biochemistry , extracellular matrix , genetics
Regeneration of injured human heart muscle is limited and an unmet clinical need. There are no methods for the reproducible generation of clinical-quality stem cell-derived cardiovascular progenitors (CVPs). We identified laminin-221 (LN-221) as the most likely expressed cardiac laminin. We produced it as human recombinant protein and showed that LN-221 promotes differentiation of pluripotent human embryonic stem cells (hESCs) toward cardiomyocyte lineage and downregulates pluripotency and teratoma-associated genes. We developed a chemically defined, xeno-free laminin-based differentiation protocol to generate CVPs. We show high reproducibility of the differentiation protocol using time-course bulk RNA sequencing developed from different hESC lines. Single-cell RNA sequencing of CVPs derived from hESC lines supported reproducibility and identified three main progenitor subpopulations. These CVPs were transplanted into myocardial infarction mice, where heart function was measured by echocardiogram and human heart muscle bundle formation was identified histologically. This method may provide clinical-quality cells for use in regenerative cardiology.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom